Invention Grant
- Patent Title: Mutated humanized 12G4 antibodies and the fragments thereof against the human anti-Mullerian hormone receptor type II
-
Application No.: US14658785Application Date: 2015-03-16
-
Publication No.: US09637544B2Publication Date: 2017-05-02
- Inventor: Christian Behrens , Isabelle Navarro-Teulon
- Applicant: LFB BIOTECHNOLOGIES , UNIVERSITE MONTPELLIER I , CENTRE NATIONAL DE LUTTE CONTRE LE CANCER , I.N.S.E.R.M. (Institut National de la Sante et de la Recherche Medicale)
- Applicant Address: FR Les Ulis FR Montpellier FR Montpellier FR Paris
- Assignee: LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES,UNIVERSITE MONTPELLIER I,CENTRE NATIONAL DE LUTTE CONTRE LE CANCER,I.N.S.E.R.M. (Institut National de la Sante et de la Recherche Medicale)
- Current Assignee: LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES,UNIVERSITE MONTPELLIER I,CENTRE NATIONAL DE LUTTE CONTRE LE CANCER,I.N.S.E.R.M. (Institut National de la Sante et de la Recherche Medicale)
- Current Assignee Address: FR Les Ulis FR Montpellier FR Montpellier FR Paris
- Agency: Young & Thompson
- Priority: FR1053712 20100512
- Main IPC: C07K16/28
- IPC: C07K16/28 ; G01N33/574 ; A61K39/395 ; A61K45/06 ; A61K39/00
Abstract:
Novel mutated humanized 12G4 antibodies, and fragments thereof, directed against the anti-Müllerian hormone type II receptor.
Public/Granted literature
Information query
